Near-atomic look at three ways to thwart SARS-CoV-2 variants

SARS-CoV-2 nanobodies—microscopic molecules developed at the University of Pittsburgh School of Medicine that neutralize the virus in animals—are remarkably active against mutations found in variants, including Delta, ...

page 5 from 21